Moreover, KRT17 expression was proposed as a prognostic marker that can discriminate postoperative stage II patients with colorectal cancer with a high probability of disease recurrence, as support to available risk stratification factors [43]. The gene discussed is KRT17; the disease is colorectal cancer.